|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Central effects of various ligands on drinking behavior in eels acclimated to seawater
Laboratory of Integrative Physiology, Faculty of Integrated Arts and Sciences, Hiroshima University, Higashi-Hiroshima 739-8521, Japan
* Author for correspondence (e-mail: mando{at}hiroshima-u.ac.jp)
Accepted 18 November 2002
Intracranial injection of eel angiotensin II (eANG II,
5x10-13-5x10-8 mol), acetylcholine (ACh,
5x10-12-5x10-9 mol), substance P
(5x10-10 mol) and isoproterenol (a ß-adrenoceptor
agonist, 5x10-11-5x10-9 mol) enhanced water
intake in the seawater eel. The effects of eANG II, ACh and isoproterenol were
dose-dependent. By contrast, water intake was inhibited by intracranial
injection of eel atrial natriuretic peptide (eANP,
5x10-13-5x10-10 mol), serotonin (5-HT,
5x10-12-5x10-8 mol), ghrelin
(5x10-12-5x10-10 mol),
-amino butyric
acid (GABA, 5x10-11-5x10-8 mol), prolactin
(PRL, 5x10-10-5x10-9 mol), arginine
vasotocin (AVT, 5x10-12 mol), vasoactive intestinal peptide
(VIP, 5x10-11 mol), noradrenaline (5x10-9
mol l-1) and phenylephrine (
-adrenoceptor agonist,
5x10-11-5x10-9 mol). The inhibitory effects
of eANP, 5-HT, ghrelin, GABA, PRL and phenylephrine were dose-dependent. The
intracranial stimulatory effect of eANG II was relatively long-lasting
compared with the intravenous effect. The stimulatory effect of intravenous
eANG II disappeared immediately, and was followed by an inhibition, which
could be well explained by an increase in eANP secretion from the atrium.
Key words: seawater eel, Anguilla japonica, drinking behavior, intracranial administration, intravenous administration, angiotensin II, atrial natriuretic peptide, circumventricular organ
This article has been cited by other articles:
![]() |
T. Tsukada, S. Nobata, S. Hyodo, and Y. Takei Area postrema, a brain circumventricular organ, is the site of antidipsogenic action of circulating atrial natriuretic peptide in eels J. Exp. Biol., November 15, 2007; 210(22): 3970 - 3978. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hashimoto, H. Fujihara, M. Kawasaki, T. Saito, M. Shibata, H. Otsubo, Y. Takei, and Y. Ueta Centrally and Peripherally Administered Ghrelin Potently Inhibits Water Intake in Rats Endocrinology, April 1, 2007; 148(4): 1638 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Pulman, W. M. Fry, G. T. Cottrell, and A. V. Ferguson The Subfornical Organ: A Central Target for Circulating Feeding Signals J. Neurosci., February 15, 2006; 26(7): 2022 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsunaga, K. Ukena, E.-E. Baulieu, and K. Tsutsui 7{alpha}-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system PNAS, December 7, 2004; 101(49): 17282 - 17287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Unniappan and R. E. Peter In vitro and in vivo effects of ghrelin on luteinizing hormone and growth hormone release in goldfish Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1093 - R1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaiya, M. Kojima, H. Hosoda, S. Moriyama, A. Takahashi, H. Kawauchi, and K. Kangawa Peptide Purification, Complementary Deoxyribonucleic Acid (DNA) and Genomic DNA Cloning, and Functional Characterization of Ghrelin in Rainbow Trout Endocrinology, December 1, 2003; 144(12): 5215 - 5226. [Abstract] [Full Text] [PDF] |
||||